7 results
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
17 Dec 21
Entry into a Material Definitive Agreement
5:17pm
they were made, not misleading.
(f) Statistical and Market-Related Data. The statistical, demographic and market-related data included
8-K
EX-1.1
0tpwwy24snha74uah
28 May 21
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-99.1
f61jx36rf
14 Mar 13
Enobosarm Phase 2 Trial for Muscle Wasting and Physical Function In Patients with Cancer Published In the Lancet Oncology
12:00am
- Prev
- 1
- Next